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Keratin KS is expressed in the basal layer of stratified epithe-
lia in mammals and its synthesis is regulated by hormones and 
vitamins such as retinoic acid. The molecular mechanisms 
that regulate KS expression are not known. To initiate analy-
sis of the protein factors that interact with the human KS 
keratin gene upstream region, we have used gel-retardation 
and DNA-mediated cell-transfection assays. We found five 
DNA sites that specifically bind nuclear proteins. DNA-pro-
tein interactions at two of the sites apparently increase tran-
scription levels, at one decrease it. The importance of the 
remaining two sites is, at present, unclear. In addition, the 
location of the retinoic acid and thyroid hormone nuclear 
receptor action site has been determined, and we suggest that 
it involves a cluster of five sites similar to the consensus 
recognition elements. The complex constellation of protein 
binding sites upstream from the KS gene probably reflects the 
complex regulatory circuits that govern the expression of the 
KS keratin in mammalian tissues. ] Invest Dermatol 99:206-
215,1992 
-------------------------------------------------------------------------------------------------------------
E pidermal keratinocytes are our first line of defense from the external milieu . Keratinocytes, on the one hand, provide mechanical protection and prevent water loss by differentiating into a strong, impermeable stratum cor-neUm [1] and, on the other hand, after epidermal injury, 
initiate immunologic protection by synthesizing and secreting 
growth and chemotactic factors for lymphocytes [2]. The most 
prominent proteins of keratinocytes are keratins, the insoluble he-
teropolymeric building blocks of epithelial intermediate filaments 
(reviewed in [3]). In the basal layer, keratinocytes synthesize kera-
tins K5 and K14, at the onset of differentiation keratins Kl and Kl 0, 
and under hyperproliferative conditions keratins K6 and K16 [4]. 
Because keratin synthesis is regulated primarily at the level of tran-
scription [5], we analyzed the molecular interactions between nu-
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clear proteins and the DNA sequences immediately upstream frorn 
the human K5 keratin gene. ' . . 
The human K5 keratin is a 58-kD protein. It belongs to the baSIC, 
type II keratin family . The protein is polymorphic; at least tWO 
allelic variants have been detected [6,7]. Its structure conforms to 
the blueprint for structures of intermediate filament proteins: the 
310 amino acid central alpha-helical domain is flanked by two non-
helical domains that, in the case of the 1<.5 keratin, are moderatelY 
rich in glycine and serine amino acids [5,8] . The human gene ~n­
coding the K5 keratin is approximately 5-kb long, contains ninE 
exons, and is located on chromosome 12 [9,10]. At least one typeo 
epidermolysis bullosa, a severe, congenital epidermal structural diS-
order, has been linked to the K5 keratin gene locus [11]. 
Keratin K5 is coexpressed with keratin K14, its partner from the 
acidic, type I keratin family [12,13]. Keratins K5 and K14 have been 
found in all stratified epithelia including epidermis, cornea, hair 
follicles, and epithelia of the digestive, uro-genital, and respirator}' . 
tracts [14- 24]. The 1<.5 keratin has been found also in pseudostratl~ 
fied epithelia and in mesotheliomas [25]. Transformed cells of strati-
fied epithelial origin no longer express K5 keratin [26 - 28]. d 
Comparison of the DNA sequences upstream from the K.5. an 
K14 genes offers no insight into the control of their coordmate 
expression [9]. The upstream regions of both genes confer epithel~­
specific expression [29]. Regulation of the K5 keratin syntheSIS Y 
retinoids [30] is effected by the interaction of nuclear receptors for 
retinoic acid with the K5 gene upstream sequences [31]. 5 
To determine the molecular mechanisms that regulate the J{ 
keratin gene transcription, we have analyzed the interactions b~­
tween the nuclear proteins and the sequences upstream from t 1 ~ 
gene by DNA-mediated cell transfection and gel-retardation met 1 
ods . We have identified five DNA-protein interaction sites, at le~t 
some of which are essential for expression and regulation of t e 
human 1<.5 keratin. 
MATERIALS AND METHODS 
DNA Co~structs To create 5' deletions of pK5CAT in whic; 
the K5 keratin gene promoter drives the expression of the CA 
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Table I. List of Oligonucleotides 
---------------------------------------------------~-----------------------------------------------
Restriction 
Number Position Site Sequence 
----------------------------------------------------------------------------------------------------
A. Forward alignment 
F-1 
F-2 
F-3 
F-4 
F-5 
F-6 
F-7 
F-8 
F-9 
F-10 
F-11 
F-12 
F-13 
F-14 
F-15 
F-16 
F-17 
F-18 
F-19 
F-20 
F-21 
F-22 
F-23 
- 100 
-130 
- 166 
- 200 
- 230 
- 300 
-333 
-366 
-400 
-430 
-500 
-516 
-542 
-650 
- 760 
-795 
- 850 
-905 
-177/-166 
- 516/-500 
-542/-517 
-542/-500 
- 831/- 814 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
Kpn I 
Xba I 
Xba I 
Xba I 
Xba I 
Xba I 
TTTTCTAGAGTAACAGAGCCACCTT 
TTTTCTAGAAGGGATAAAAAGGGGC 
TTTTCTAGACAGCTCGACAGCTCTC 
TTTTCTAGAGCCCCCCAGGCATGCC 
TTTTCTAGATGTGCAGGTGTGACCG 
TTTTCTAGATGCTCGAAGGCAAGGT 
TTTTCTAGAAGCAGCGTCACCAACT 
TTTTCTAGAAGCCCCAGCCTCTATG 
TTTTCTAGACCTCAGTTCCTGGCAT 
TTTTCTAGAGAGTCCCAGGACACTG 
TTTTCTAGACCCAAGCTCCAAGGGC 
TTTTCTAGAGCTGATGGACAGCTTC 
TITGGTACCGATCACTGGGGAATCG 
TTTTCTAGAGAAACTCTATTTTCCC 
TTTTCTAGAGGCGCTGAGGGCTTCC 
TITTCTAGAACCTGGCCTTAAAGAG 
TTITCTAGAGAAAAGGTCAAAGGGC 
TTITCTAGAGGATCCCCGGGTTTCC 
GGGCTTAATCATCAC 
GCTGATGGACAGCTTCC 
GATCACTGGGGAATCGTITGCCCCCC 
GGGGATCACTGGGGAATCGTITGCCCCCCGCTGATGGACAGCTTCC 
GGGAAAAATGCTGAGTTAGGA 
B. Reverse alignment 
R-1 - 006 Pst I TITCTGCAGCTTGTTCCTGGTGGAG 
R-2 _ 006 Hind III TIT AAGCTTCTTGTTCCTGGTGGAG 
R-3 - 070 Pst I TITCTGCAGCTCAGCAGGACGCAGA 
R-4 -100 Pst I TITCTGCAGCCCAGGAACGGTGATG 
R-5 - 133 Pst I TITCTGCAGCAGAACTGGGCTGGGC 
R-6 -170 Pst I TITCTGCAGTGA TT AAGTGGGCTGG 
11.-7 - 200 Pst I TTTCTGCAGCAGCTGTGAGCTCACC 
R-8 - 200 Xba I TTTTCTAGACAGCTGTGAGCTCACC 
R-9 _ 270 Pst I TITCTGCAGGCTCAGTT AGAAA T AA 
11.-10 - 300 Pst I TTTCTGCAGACTGATCTCTTGGCAA 
R-11 _ 333 Pst I TITCTGCAGT AGCAAGT A TGTCTTC 
R-12 - 370 Pst I TITCTGCAGAGCAGCCCAAAAAGGA 
R-13 -400 Pst I TITCTGCAGGGGGCATTGGCATGGC 
R-14 - 500 Hind III TITAAGCTTGGAAGCTGTCCATCAG 
R-15 -600 Hind III TITAAGCTTAATCTGTAGCCTTATA 
R-16 -740 Pst I TITCTGCAGATGTGGGAAGCCCTCA 
R-17 -795 Pst I TITCTGCAGTITATCCTTCCATAGC 
R-18 -177/-166 GGGGTGATGATTAAG 
R-19 - 516/- 500 GGAAGCTGTCCATCAGC 
R-20 _ 542/- 517 GGGGGGCAAACGA TTCCCCAGTGATC 
11.-21 _ 542/- 500 GGGGGAAGCTGTCCATCAGCGGGGGGCAAACGA TTCCCCAGTGATC 
R-22 - 831/-814 GGGTCCTAACTCAGCATTTTT ~--------------~------------------------------------------------------------
repo t tellJ. r
l 
er gene, we used the polymerase chain reaction (PCR). The 
1<.5 pate, pK5CAT, contains 905 bp of the promoter of the human 
sy gen~. DNA primers were synthesized on a Pharmacia Gene-Plus 
pttheslzer. Each primer has 16 nucleotides hybridizing to its tem-
tidte and at its 5' end, a restriction site and three additional nucleo-
en es (1'1'1') that facilitate complete digestion with the restriction 
as ~~rnes. The distal (forward) primers contain an Xba I site, where-
tio e pr~xlmal (reverse) primers, just upstream of the ATG trans la-
litdlnltl~tion codon, contain a Pst I or a Hind III site. We used 
PSt~ III In proximal primers at -795, -850, and -905 because of the 
1'hslte at position -575. All the primers are listed in Table I. 
ase e PCR was performed using Thermus aquaticus DNA polymer-
CetUn)der conditions suggested by the manufacturer (Perkin Elmer 
sho Us. Amplified DNA was digested with the restriction enzymes 
PG~n above and ligated into similarly digested and gel-purified PGC~ l' vector. The sequences of all the fragments inserted into the 
qUe T vector were confirmed using the di-deoxy plasmid se-
l' nClI1g method. 
frag 0 rnake an internal deletion of construct -542, we prepared two 
rnents; one was amplified by PCR using the distal primer con-
taining a Kpn I site (F-13) and the proximal primer containing an 
Xba I site (R-8), whereas the other was amplified using the distal 
primer containing an Xba I site (F-3) and the proximal primer 
containing a Pst I site (R-1; Table I). These two amplified DNA 
fragments were digested with Kpn I and Xba I, and with Xba I and 
Pst I, respectively. The two digested fragments were ligated into the 
pGCA T vector digested with Kpn I and Pst I. 
Probes and Competitors for Gel-Retardation Assays Larger 
fragments (> 50 bp) to be used as probes were made by PCR as 
described in DNA Constructs, using the same template, distal 
primers containing an Xba I site and proximal primers containing a 
Pst I site or a Hind III site. Amplified DNA were purified through 
gel electrophoresis in 1.5% agarose gel, digested with appropriate 
restriction enzymes, and then radioactively labeled by use of the 
Klenow fragment and [a-32P)dCTP (50 fJ.Ci per reaction, 3000 
Cijmmol), followed by standard gel filtration using Sephadex 
G-50. At times, desired end-labeled DNA fragments were isolated 
from polyacrylamide gels by the method described (32) to remove 
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Figure 1. Structure of K5 promoter. The top lirle represents 905 bp of the 
promoter DNA with the ovals showing proteins binding to sites A-E. 
Double-headed arrows represent the eight segments used in gel-retardation 
assays. They are marked with roman numerals. Below them, the open boxes 
mark the junction probes used for testing the binding sites that straddle the 
four proximal segments. Solid boxes represent smaller fragments used as 
probes or competitors in gel-retardation assays. 
contaminating radioactive fragments, so that cleaner background 
could be obtained in autoradiography. 
Smaller fragments « 50 bp) to be used as probes were designed so 
that they contain 5' -overhangs (GGG) for the [a-32P]dCTP end-la-
beling reaction as shown in T able I (5 ' -overhang GGG is italic). 
Those fragments were generated by annealing the two complemen-
tary strands, both of which were made by oligonucleotide synthesis, 
and were thereafter end labeled as described above. 
Fragments of the K5 promoter to be used for competition were 
also made either by amplification with PCR or by annealing the 
complementary strands produced by oligonucleotide synthesis. 
Promoter DNA from other keratin genes, namely, K6, KI0, and 
K 14, have been described [29] . The lengths of those promoters are 
390, 1200, and 280 bp, respectively. Those promoter DNA cloned 
into pGCAT vector were excised with Pst I and Hind III , gel puri-
fied, and used for competition assays. In addition, the K6 keratin 
gene promoter was divided into three segments of approximately 
the same size in a way similar to the K5 promoter. They were also 
created by amplification with PCR. 
During purification of DNA fra gments to be used as probes or 
competitors, Spin-X centrifuge filter units containing a 0 .221J.m 
cellulose acetate filter (Costar, Cambridge, MA) were used. An 
elution buffer containing 0.5 M ammonium acetate (pH 7.5) and 
1 mM EDT A was used for recovery of DNA from agarose gels, and 
a buffer containing 0.5 M ammonium acetate, 10 mM magnesium 
acetate, 1 mM EDT A (pH 8.0), and 0.1 % SDS for recovery from 
polyacrylamide gels as described [32] . 
Nuclear Extracts Nuclear extracts from H eLa cells were pre-
pared as described [33], wi th a few modifications. Several protease 
inhibitors, i.e., 0.5 mM PMSF, 1 mM benzamidine, 0.5IJ.gj mlleu-
peptin, and IlJ.gjml pepstatin A (final concentration), were added to 
the homogenization buffer and th e dialysis buffer. The extracts 
were stored in aliquots at -70 ° C until use. Protein concentrations 
were measured as described [34]. 
Gel-Retardation Assays · Gel-retardation assays were conducted 
as fo llows. Five micrograms of extract protein was incubated with 
approximately 5 X 104 cpm of end-labeled, double-stranded DNA 
fragment in the presence of2IJ.g of poly(dl-dC) poly(dl-dC) (Phar-
macia) in a final volume of 25 IJ.I. Binding reactions also contained 
20 mM Tris H C I (pH 8), 100 mM N aCI, 1 mM DTT, 5 mM 
MgCI2 , 10% glycerol, 2% polyvinylalcohol, and 0.1 mM EDTA 
(final concentration). Incubations were carried out at room tempera-
ture for 30 min. For competition, the mixture of extracted protein 
and a hundredfold molar excess of unlabeled competitor DNA was 
pre-incubated at room temperature for 15 min before a probe was 
added. Samples were subjected to electrophoretic separation at room 
temperature on a 6% nondenaturing polyacrylamide gel (29: 1 
acrylamide: bis-acrylamide), at 125 V for 1.5 to 2 h. After electro-
phoresis, gels were exposed to X-ray film at room temperature or 
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-70°C for 6-16 h. Densitometry of autoradiograms was per-
formed with Image 1 AT (Universal Imaging Co.). 
Column Chromatography of Nuclear Proteins T ype I hepa-
rin-agarose (Sigma, St. Louis, MO) and a fast protein high-perfor-
mance liquid chromatography system (Pharmacia LKB, Piscataway, 
N]) were used. All chromatographic experiments were carried oUJ 
at 4 ° C. A 1.6 X 10 cm column ofheparin-agarose was prepared an 
equilibrated with 0.15 M KCI in 500 ml of 20 mM HE PES (pH 
7.9) , 20% glycerol, 0.2 mMEDTA, 0.5 mM phenylmethylsulfon~! 
fluoride (PMSF), 0.5 mM DTT, 1 mM benzamidine, 0.5 IJ.g/rw 
leupeptin, and IlJ.g j ml pepstatin A. Nuclear extracts from HeLa 
cells (approximately 5 g) were applied directly to the column, afte~ 
which unbound proteins were removed by washing for 4 min Wit 
1 ml of the starting buffer. Proteins bound to heparin-agarose were 
eluted at a flow rate of 15 mlj h with a linear salt gradient that 
ranged from 0.15 M to 0.5 M KCI. Both the flow-throu gh and the 
column fractions were collected. 
Cell Transfection and Enzyme Assays 3T3 and HeLa cells 
were maintained in Dulbecco's-modified Eagle's medium suppl~; 
mented with 10% calf serum. All cells were grown at 37 ° C in a ~~o 
CO2 atmosphere in media containing penicillin and streptomyc.1d· All DNA samples were purified by two CsCI-ethidium bro1U1 e 
equilibrium-banding centrifugations. The transfection procedure as 
described [35] was slightly modified. One day before transfectlon, 
cells were plated onto 100-mm dishes. Four hours before trans fec-
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Figure 2. Protein binding to site A. Segment II was used as a probe in 1 a~; 
the 12-bp fragment, bp -177/-166, inB. The 12-bp fragment was rna e I e 
annealing oligonucleotides F-19 and R-18 from Table I, and contains d'f 
binding site A. Specific retarded bands are marked with solid arrows. T and 1l 
mark the top of the gel and the free DNA, respectively. Tracks U an" a 
represent unbound (without protein) and bound DNA, respectively, ~e 
binding competitor, tracks 1-V contain segments 1- V; tracks II-1.2I :he distal and prOXimal two thirds of segment II, respectively; tracks K6 I-II IS 
DNA segments from the K6 keratin gene promoter equivalent to segrn~ 4 
I - III from the K5 promoter; and tracks KIO and KI4 the KIO and he 
keratin gene promoter DNA, respectively. In B, track site A contaIns \e 
same 12-bp fragment as the probe for competition. Below the panel~s ~re 
structure of the KS promoter, the segment II probe, and the competitO 
shown. 
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tion, the medium was changed. For each transfection, a mixture of 
5 Ilg of one of the plasmids with CAT inserts, 2 J.lg of pRSVZ, and 
13llg of carrier (20 J.lg total DNA) was prepared. pRSVZ contains 
theJac Z gene downstream from the Rous sarcoma virus regulatory 
region and serves as an internal control for efficiency of transfection. 
The cells were harvested after 48 h and disrupted by sonication. 
Human epidermal keratinocytes from foreskin (HEK) were pur-
C?ased from Clonetics (San Diego) . They were passaged by 1: 5 
dilutIOn two times and expanded into 100 to 150 plates, 60 mm 
each, at seeding densities between 2500 and 5000 cellsjcm2 • Cells 
Were grown in keratinocyte serum-free medium (GIBCO). Sub-
honfluent cultures were transfected at 80% conf!uency . . Forty-eight 
h Ours after transfection, cells were washed on plates with P~S and 
arvested by scraping into 15 ml of PBS, collected by centnfuga-
tlon, and washed once more in PBS. Each pellet was resuspended in 
150 III of 0.25 M Tris buffer, pH 7.8 . Cells were disrupted by ultra-
soniC bursts of120 seconds using an ultrasonic homogenizer sonica-
tor (Cole-Parmer Instrument Co.). Cell debris was removed by 
~entrifugation and 50 J.ll of the supernatant was used in p-galactosi-
ase assay. The remainder of the supernatant was heated at 65 ° C for 
10 min, clarified by centrifugation, and stored at - 20°C until 30-
60.u1 Were used in the CAT assay as described [31] . The CAT and 
the II-galactosidase (B-GAL) activities were determined in the same 
sample of cell extract. The values in Fig 8 represent promoter activi-
ties corrected for the efficiency of transfection. 
RESULTS 
Overall Strategy To determine the protein-binding sites in the 
Upstream DNA, the 905-bp sequence was divided into eight seg-
tnents of approximately the same size. These are marked with 
rOman numerals I - VIII (Fig 1). Each of the segments was amplified 
111 a PCR reaction and radioactively labeled. The labeled segments 
Were mixed with nuclear protei11S from HeLa cells and analyzed on 
ntndenaturing gels. This technique does not exhaustively identify ~ I protein-binding sites . Proteins in very low abundance, those 
enatured by the isolation procedure, and those that do not bind to 
, 
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IV ~ '"" IV-, IV-2 
t::. c~~re.3: Protein binding to site B. Segment IV was used as a probe. For 
and ~:tltlon, tracks VI and VII contain segments VI and VII, respectively, 
tiYel (cks IV-1,2 the dIstal and proximal two tlurds of segment IV, respec-
Y see the scheme below). Other markings are the same as in Fig 2. 
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Figure 4. Protein binding to site C. Specific retarded bands are marked with 
solid arrows, nonspecific bands with opel! arrows. Other markings are as in Fig 
2. In A, binding to segment V is shown on the lift, to segment VI on the right. 
Tracks II, IV, V, VI, VII, and VIII contain the corresponding segment for 
competition. In B, binding to segment VI, continued from the right part of 
A, is shown. Track site C contains the 17-bp fragment -516/-500 overlap-
ping segments V and VI (see the scheme below), which was generated by 
annealing complementary oligonucleotides F-20 and R-19 from Table I. 
Tracks K6, K10, and K14 contain the corresponding keratin gene promoter 
DNA for competition. Note that the identical doublet of specific retarded 
bands (solid arrows) are seen both with segment V and with segment VI, and 
that segments V and VI compete with each other. 
DNA under our test conditions will not be observed in gel-retarda-
tion assays. However, we observed that the migrations of five of the 
segments were retarded by the nuclear protei11S (see below). These 
were segments II, IV, V, VI, and VIII. 
We localized the binding sites within the segments using compet-
itor DNA in the retardation assay. The two competitor DNA for 
each segment contain either the distal two thirds or the proximal 
two thirds of the segment. The rationale for this approach is that if 
either competitor competes for the protein binding, the binding site 
is in the corresponding terminal third, but if both compete, the 
binding site is in the middle third. The position of the binding site is 
thus narrowed down from an approximately lOO-150-bp segment 
to a 35 - 50-bp sequence. Another round of testing by thirds local-
izes the binding site to 15 - 20 bp. 
A protein binding sequence could straddle adjacent pair of seg-
ments, which would preclude its detection in our experiments. To 
analyze the junctions between the proximal segments we have syn-
thesized the overlapping fragments . The distal segments were de-
signed so that they overlap by at least 20 bp to avoid this problem 
(Fig 1). 
Additionally, we wanted to determine whether the protein-bind-
ing sites in the K5 keratin gene promoter are shared by the upstream 
regions of other available human keratin genes, namely, K6, KI0, 
and K14. The DNA containing promoters for these genes were used 
as nonlabeled competitors in gel-retardation assays. 
Protein Binding Site A The most proximal binding site we 
found is in the segment II between -100 and -200 (Fig 2). The 
binding is specific because it is competed by the same segment (Fig 
2A, track II), but it is not competed by the other seven segments 
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Figure 5. Protein binding to site D, adjacent to site C. The fragment 
-542/-500 conta.ining both sites C and D was used as a probe. Competitors 
are in track sites C + D, the same fragment -542/-500; in track site D, 
-542/-517 containing only site D; and in track site C, -516/-500 containing 
only site C. Note that the top band is eliminated when the site D-containing 
fragment is added, whereas both bands of the doublet right above the nonspe-
cific band (opetl arrow) are eliminated when the site C-containing fragment is 
added. The competing fragments were generated by annealing the corre-
sponding complementary oligonucleotides from Table I. 
(tracks I, I1I-V, and data not shown) . Only the distal two thirds 
competed for binding (track II-I), which means that the site is in the 
distal third. Further localization determined that the protein specifi-
cally binds to the 12-bp sequence CTTAATCATCAC between 
positions -166 and -177 (Fig 2B). Promoter DNA from keratin K6, 
KI0, and K14 did not compete for binding (Fig 2A). 
Protein Binding Site B Segment IV contains a protein-binding 
site that does not compete for binding with the other segments (Fig 
3, tracks I-VII). The binding site is in the distal two thirds of 
segment IV between positions -333 and -400, because the same 
specific retarded band was detected when we used the distal two 
thirds as a probe. The site could not be localized further, because 
although both the distal two thirds and the proximal two thirds 
competed for binding (Fig 3, tracks IV-l ,2), competitor DNA 
smaller than the middle third did not reduce the binding. Promoter 
DNA from the K6 gene did not compete, but, at high concentra-
tions, KlO and K14 promoter DNA did (Fig 3). 
Protein-Binding Sites C and D Both segments V and VI were 
retarded by protein, each forming a doublet of retarded bands (Fig 
4A). Segments Vand VI compete with each other for the binding to 
the doublet proteins, which indicates that the proteins bind to the 
overlap sequence common to the two segments (tracks Vand VI). A 
relatively short, 17-bp sequence between -500 and -51 6, 
GCTGATGGACAGCTTCC, competes for binding to both bands 
of the doublet. We call this sequence site C (Fig 4B). Promoter 
DNA from keratin K6, KI0, and K14 did not compete for binding 
(Fig 4B). The doublet of retarded bands seen in site C means that 
there are at least two different protein-DNA complexes formed: the 
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DNA segment could either have two different binding sites in .the 
17 -bp short sequence or could bind two proteins to the same site. 
Adjacent to site C, between positions -517 and -542, binding site 
D was found . We synthesized two double-stranded oligonucleo-
tides, one containing site C (-516/-500), the other containing site D 
(-542/-517; see Fig 1 and Table I) and used them in the competitiOn 
assay with the fragment containing both sites (-542/-500) as a 
probe. The first oligonucleotide competed with both bands of ~he 
doublet characteristic of the protein binding to site C, but not with 
the top band characteristic of the binding to site D. The reverse ,:"as 
the case for the second oligonucleotide (Fig 5). This observation 
suggests that these two adjacent sites are distinct and bind to differ-
ent proteins. 
Protein Binding Site E The most distal segment, VIII, has twO 
retarded bands, which means that it forms two protein complexes 
(Fig 6). Both bands were competed with the two-third competitors 
(Fig 6A, tracks VIII-l,2), which indicates that proteins bind to the 
middle third. The other segments of the K5 promoter and . the 
promoter DNA from other keratin genes did not compete for biOd-
ing (Fig 6A). We have constructed the "next generation" of tw°d third competitors within the middle third of segment VIII ad 
found that both competitors abolished binding to the twO ban s 
(Fig 6B) . Because we were unable to uncouple the two bands we 
suggest that they represent protein binding to the same site. CO~­
mon to the two competitors is the 18-bp sequence AAAAATGC -
GAGTTAGGA. 
Junctions Between Segments Specific oli'gonucleotide pairs 
spanning the junctions between non-overlapping segments w,ere 
generated by PCR and radiolabeled. All junction oligonucleotld~S 
showed nonspecific binding (data not shown), except that in t e 
case of junction IV-V DNA, the binding may be specific; we have 
not characterized this further. 
Separation of Nuclear Proteins using Column Chromatogra' 
phy To characterize the proteins that bind to the K5 promoter Nu-DNA, we have separated them on a heparin-agarose column. . 
T 
F 
F 
VI1I -l VIII., 
VIII ' 3---
VIII _ .. - _ VIII- 5 
. JI 
Figure 6 .. Protei~ binding to site E. ~egment VIII was used as a probe I~or 
and the middle third of segment VIII m B. The markmgs are as m Fig Zd'ng 
competition, in A, tracks II, IV, V, VI, and VIII contain the correspond lof 
segment. Tracks VIII-l,2 contain the distal and proximal twO-thlr 5the 
segment VIII, respectively. Tracks K3, K6, KI0, K14, and K16 contain the 
corresponding keratin gene promoter DNA. In B, track VIII-3 contalllS[lIaJ 
middle third of segment VIII, and tracks VIII-4,5 the distal and pro"l [lie 
two thirds of the middle third of segment VIII, respectively (see the sche 
below A). All the competitors used in B contain the binding site £. 
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D FI 
U B C C;;, Cm FI 1 2 3 4 5 6 7 8 9 10 
E 
M KCI 0 0 
0.8 ,----------------------------------------60 
0 .6 
v- 40 
0 .• 
V-
I( 
30 
0 .3 
--:(/ ~ 0 .2 
0.1 I 0 . I 
20 
10 
F I 2 3 • 6 8 7 8 9 10 
-. - KCI -+- Protein _ Site A binding ri'&'lS l te E binding 
Figure 7. Column chromatography separation of binding proteins. HeLa 
cell nuclear extracts were separated on a heparin-agarose column with a 
linear salt gradient. Fractions were then tested for the presence of the bind-
ing activity to site A inA; site B inB, site C in Cand siteE inDo The it!setinD 
shows a longer exposure of the gel. Probes are in A) the 12-bp fragment 
-177/-166; B) the distal two thirds (-400/-333) of segment IV; C) segment 
VI; and D) the 17-bp fragment -831/-814. Specific retarded bands are 
marked with solid arrows, nonspecific bands with opet! arrows. Tracks U and B 
represent unbound and bound DNA, respectively. Tracks C contain the 
same DNA for competition. Tracks Fl contain the flow-through, Cm, the 
combined fractions and the numbered tracks every other column fractions. E 
shows the elution profiles of the binding activities to sites A and E with the 
salt and protein concentrations in the fractions. The left axis 'lUmbers repre-
sent both molarities ofKCI and total protein concentrations in mg/ml. The 
right axis numbers represent relative values from densitometric scanning of 
panel A (site A binding) and D (site E binding). 
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A 
U B s~e B U B sMe 
-
Figure 8. Proteins eluted from heparin-agarose column retain binding spec-
ificity. Binding to site A (fraction 9 from Fig 7A) is shown in A, to site E 
(fraction 5 from Fig 7D) inB. The same DNA as the probes inFig 7A,Dwere 
lised as specific competitors. 
clear extracts from HeLa cells were bound to the column in a low 
salt concentration buffer, the column was extensively washed with 
the same buffer, and then the bound proteins were eluted with a 
linear sal t gradient. 
Both the flow through and the column fractions were tested for 
the presence of the K5 promoter DNA binding activity. Each sam-
ple was used in gel-retardation assays with four small fragments 
containing the binding sites described above . To guard against the 
possibility that subunits of multimeric proteins could be separated 
on the column and thus lose their binding capacity, we have also 
combined aliquots of all fractions and used the combination in the 
gel-retardation assay. 
Our results are shown in Fig 7. The protein that binds to site A 
eluted at a salt concentration higher than the concentrations for the 
other proteins (Fig 7 A). The result in Fig 7 A cannot be used for 
quantitation of the binding activity because higher salt concentra-
tions enhance the binding of the protein to site A (M. Ohtsuki and 
M. Levin, unpublished). In general, the binding activities in the 
purified fractions were much less stable than those in the crude 
nuclear extracts, and could not be detected after a few weeks of 
storage at -70 C C (data not shown) . 
Site B binding activity was detectable in fractions eluted at 0.36 to 
0.43M KCI apart from other nonspecific bands, but it was very weak 
(Fig 7B). In part due to its ':'leak activity, and in part to its instability, 
we were unable to confirm that this activity is specific for site B. 
The proteins that bind to sites C and D were not recovered from 
the column; perhaps they were degraded during the procedure. A 
protein forming nonspecific bands eluted as a broad peak (Fig 7C). 
On the other hand, site E binding activity eluted as a broad peak at 
0.29 to 0.43 M KCI (Fig 7D). It is clearly distinct from the site A 
binding protein in its elution characteristics (Fig 7E) . Figure 8 dem-
onstrates the specificity of the binding to sites A and E by testing the 
peak fractions after a heparin-agarose column separation using spe-
cific competitors in gel-retardation assays. 
Functions of the Binding Sites A series of DNA constructs 
containing combinations of the binding sites was tested by trans fec-
tion into eukaryotic cells. Nested deletions of the upstream DNA, as 
shown in Fig 9A, were constructed in front of the CAT reporter 
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Figure 9. Transfection ofKS promoter deletion constructs. The constructS, 
linked to the CAT reporter gene (box), are shown inA. Protein bindingsl~~ 
A-E are marked on the top. Arrows represent the fragments of the 
promoter and their numbers the corresponding lengths. -dS42 contaiOS an 
internal deletion of site A, as indicated. The constructs were trans fee ted IncO 
3T3 fibroblasts, HeLa cells, and HEK. The ordinates in B represent relattve 
CAT activities. 
gene and trans fcc ted into 3T3 fibroblasts, HeLa cells, and primarY 
cultures ofHEK. Because the activities of all constructs were unde-
tectable or barely detectable in the fibroblasts, we shall focus on the 
two epithelial cell types, HeLa and HEK. t 
The protein binding site E, at -814 to -831, apparently does nOt 
play a significant role in these cell types because all three large~ 
constructs had similar activities. Between positions -542 and -7? ' 
there may be a keratinocyte-specific regulatory site because delet~~ 
this DNA significantly reduces the promoter activity in HEK, U 
not in HeLa cells (Fig 9B). 
Binding site D is very important for promoter function, becaus~ 
the construct -516, which lacks site D but not site C, is nonfunc f 
tiona!' Additional deletion of site C did not restore the function ° 
the promoter. 
Binding site B may contain a negative regulator: deleting tf 
quences -333 to -366, which contain site B, restores a low leve /1 
activity to the K5 promoter. This effect is evident in both epithe la 
cell types (Fig 8B). d ~ite A is .e~sential for the ~u?-ction of the K5 promoter. A matC;e7, pair of deletions, one contammg bp -1 to -165, the other -1 to -1 11 
would not be appropriate for testing of the function because a _ 
constructs containing less than 300 bp were nonfunctional in tra~:e 
fection assays. Therefore, we constructed an internal deletion of S!th 
A by synthesizing the upstream and downstream fragments w; n 
Kpn I and Xba I sites, and Xba I and Pst I sites, respectively, ted 
digesting them with the corresponding restriction enzymesd jst 
ligating the two fragments to each other into a Kpn I - an 
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§ C'rocGcAATCGTTTGCCCCCPCTGATGGACAGCTTCCfcru.GCTCCJ\J\GGGCAGGT -481 
Gc'rcAGCATGTACCGTAC'l'GGGATGGTTGTCAATACTCCTGG~TAAGAGTCCC~ 
~CTGcCATGCCJ\J\ GTTCCTGGCATCCTTTTTGGGCTGCTCACAGCC 
GCCTcTATGGTGAAGACATA~CT GCG~CAACTTGTTGCCA1\GAGATCAG 
TcCTCCAAGG~TTTCTAA~GAGCCTGCCAGGAAGAAAGCGTTTGCAC 
CCCACACCACTG=GGTG~ACCGGTGAGCTCACAGCTG~CCCCCAGGCATGCCCAGC 
A ~ CC§AATCAT CA GCTCGACAGCT=CGCCCAGCCCAGTTCTGGAAGGGATAAAA 
- 361 
-241 
-121 
A~TCACCGTTCCTGGG~CAGAGCCACCTTCTGCGTCCTGCTGAGcrCTGTTCT 
CTCCACCACCTCCCAACCCACTAGTGCCTGGTTCTCTTGCTCCACCAGGAACAAGCCACC ATG 
Met 
F~gure 10. Sequence ofK5 Promoter. Sites A-E are boxed. Triangles bracket 
t ~ fragment deleted in -d542 construct. The sequences similar to the RA 
an. 1'3 nuclear receptor recognition palindrome half site, GGTCA, in either 
Onentation, are ullderlined. A cluster of half-sites centered at -200 is doubly 
underlined. "Met" marks the translation initiation codon. 
I-d' Ig.ested vector. The resulting construct extends to bp -542, but 
COntains an Xba I restriction site instead of the binding site A. This 
COnstruct was nonfunctional (Fig 9B) . 
The engineered Xba I site allowed us to re-insert the 12 bp site A 
Sbtuence on an Xba I cassette. In the resulting construct, presum-
a y because of the two Xba I si tes flanking the 12 bp msert, the 
prOmoter function was not restored (data not shown). 
Regulation by Nuclear Receptors Human epidermal keratin gene~ are regulated by RA and T3 through the action of their re-
Spective nuclear receptors [31]. Vitamin D3 and its receptor do not 
regulate epidermal keratin genes directly [36]. The K5 keratin gene ~romoter sequence has several individual consensus half-sites recog-
b:~~d by .RA and T3 receptors (Fig 10), but the receptors, which 
their as ~Imers [37,38], require clusters of consensus .half-sltes for 
40-b actIOn [39]. One such cluster with five half-sites wlthm a 
T P sequence is found centered at -200 bp (Fig 10). . . 
w h determine the location of the nuclear receptor responsive site, 
we have Co-transfected three of the constructs described in Fig 9A 
S It the Vectors expressing nuclear receptors for RA and T3. 
th
tnaller constructs, those missing site B, were inactive and therefore 
~ I h . F' re~u ation by RA and T3 could not be assessed. As sown m s~g 11, In the presence of their respective ligands, both receptors 
w&p~ssed promoter activities of all three K5 constructs tested, 
pi IC IS consistent with our prediction that the cluster at -200 may 
Inay ~ ro le In regulation of the K5 keratin expression by RA and T3. 
by Phlmary cultures of keratinocytes, the K5 promoter is regulated 
sh t e endogenous receptor (M. Tomic and C.-K. Jiang, data ·not 
veOwn). Because HeLa cells have no endogenous T3 receptor., and 
de( low levels of RA receptor, it is not surprising that we did not dat~Ct any nuclear proteins binding to the -200 region in gel-retar-
On assays. 
DISCUSSION ~h: Complex regulation of expression of the K5 keratin prompted 
tein 0 Investigate the molecular interactions between nuclear pro-
tive s and the DNA upstream from the human K5 gene. Both posi-
as and negative factors playa role in regulation of K5 expression, 
eXpected from the turn-on of K5 in the basal layer of stratified 
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epithelia and its subsequent shut-off in the suprabasal layers; the 
turn-on in urothelium in culture, and the shut-off in vivo [24] as 
well as other similar reactions . 
The upstream regulatory region of the K5 keratin gene binds at 
least five different nuclear proteins from HeLa cells . We have cho-
sen HeLa cells because they are a prototype of epithelial cell lines 
and our previous results indicate that the cloned K5 promoter is 
active in HeLa cells [29]. Of course, other cell types, e.g., epidermal 
keratinocytes, may use a different, possibly overlapping set of nu-
clear proteins to regulate the K5 expression. The five binding sites 
are marked A-E in Figs 1 and 9. At least two sites bind positive 
regulators, A and D; one appears to bind a negative regulator, site B; 
for one the role was not determined, site C; and the most distal site E 
does not seem to have a function under the conditions we tested. 
The gel-retardation assays preferentially detect the most abundant 
nuclear binding proteins. Such proteins are most commonly, but not 
always, the ones effecting transcriptional regulation. At present, we 
do not know whether the binding proteins are unique to HeLa cells, 
ubiquitous, or characteristic for certain cell types, but experiments 
designed to answer these questions are in progress. In addition, a 
cluster of potential recognition sites for the RA and T3 nuclear 
receptors has been identified in the proximal region (Figs 10 and 
11). The number and complexity of the regulatory sites reflect the 
complexities of the regulatory mechanisms that govern the eJGPres-
sion of the K5 keratin. 
We have not detected significant competitions among the five 
binding sites, which means that each protein binds separately to its 
own site. The proteins can be separated physically. Even the pro-
teins that bind adjacently to each other, at sites C and D, do not seem 
to cooperate in binding. The simplest model then has five proteins 
binding at five sites to perform five tasks . 
Site E, the most distal site, bears resemblance to an AP-1 binding 
site (TGAGTTA versus TGAGTCA). A site similar to the KER-1 
site of the K14 gene (CCCTGCAGCA versus CGCTGCAGCG 
[40]) can be found centered at position -575, a cAMP-responsive-
like site (TGACCTCA versus TGACGTCA) at -210 and a poten-
tial serum responsive element (CACCCCAC) at -238 (Fig 10) . An 
AP-2 site (CCCCAGGC) is found centered at position -194, in the 
vicinity of site A. However, no binding of He La nuclear proteins to 
this site was observed. Purified AP-2 protein can bind to this site in 
vitro [41], but its relevance in vivo is unknown. No other sites 
commonly found in promoters, such as SP-1 sites and TAT A boxes, 
are obvious in the K5 gene upstream sequences [42]. 
% CAT ACTIVITY 
120 
100 
80 
80 
40 
20 
0 
905 542 333 
Figure 11. Regulation by nuclear receptors. The constructs containing 
905,542, and 333 bp of the K5 promoter DNA (see Fig 9A) were co-trans-
fected with the vectors expressing the RA and T3 receptors in the presence of 
the respective ligands. CAT levels of the constructs alone were taken as 
100%. The suppression levels of all three constructs are approximately the 
same, which means that the nuclear receptor recognition site is entirely 
within the shortest, 333-bp construct. 
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The promoter of the K5 keratin is epithelia specific [29], which 
seems to be an intrinsic property, because none of the deletion 
constructs described in Fig 9 was functional in nonepithelial cells. 
Other epidermal keratin gene promoters are also epithelia-specific 
[29] and therefore we expected that the promoter DNA of other 
keratin genes bind some of the proteins in common with the K5 
promoter DNA. However, the only competition we observed was 
with relatively high concentrations of KlO and K14 DNA. These 
three promoters (K5, K10, and K14) have a sequence GTGAAGA 
in common, but its importance is unknown at present. Because 
other keratin promoters do not have this sequence, we believe it is 
more likely that keratin promoters intrinsically specifically recog-
nize the transcriptional machinery of epithelial cells. 
Both HeLa cells and HEK are epithelial in origin, but they show 
an interesting difference in the expression of the -542 construct (Fig 
9). This construct is expressed only in HeLa cells, but not in HEK. 
The most likely explanation for this difference is that in the -542 to 
-795 region there may be a positive regulatory element essential for 
the function in keratinocytes, but superfluous in HeLa cells. 
One of the functional similarities between the K5 promoter and 
other epidermal keratin promoters is their down-regulation by the 
nuclear receptors for RA and T3. In the K5 promoter as well as in 
the K10 and K14 promoters, in the transcriptional start site proxi-
mal sequences, one finds a cluster of receptor recognition half-sites. 
Although the primary DNA sequences are not similar, the clustered 
arrangements of the half-sites are. This clustering and the proximity 
to the transcription start may be important for the regulation by RA 
and T3 [39]. 
In summary, our experiments demonstrated five different pro-
tein-DNA interactions upstream from the human K5 gene, local-
ized the sites ' of interactions, showed the function of three of the 
interactions, preliminarily characterized the proteins involved, and 
narrowed down the location of the nuclear receptor recognition 
sites. These results bring further understanding to the molecular 
mechanisms that regulate the expression of the K5 keratin. 
We thank G. Akerkar and E. Savtchenko Jar sequence analysis, Dr. D. Yang Jar 
HeLa cells, D. Murphy Jor derlSitometry, and especially Dr. C. K. jiatlg, 1. Sunje-
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